Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2383

TDMS Study 05002-05 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                        GAMMA-BUTYROLACTONE


NTP Experiment-Test: 05002-05                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/02/94
Route: GAVAGE                                                                                                     Time: 17:49:23




       Facility:  Southern Research Institute

       Chemical CAS #:  96-48-0

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      225.         450.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          19           16           14                                                  
    Dead                                               3            7            6                                                  
    Dosing Accident                                                              2                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                28           26           28                                                  
    Dead                                                            1                                                               
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (24)         (50)                                                
      Serosa, Inflammation, Chronic                    1 (2%)                                                                       
   Intestine Large, Colon                             (48)         (20)         (49)                                                
      Infiltration Cellular, Lipocyte                  1 (2%)                                                                       
      Parasite Metazoan                                6 (13%)      2 (10%)      7 (14%)                                            
   Intestine Large, Rectum                            (48)         (20)         (43)                                                
      Parasite Metazoan                                                          1 (2%)                                             
   Intestine Small, Ileum                             (47)         (20)         (45)                                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Basophilic Focus                                 1 (2%)                    1 (2%)                                             
      Basophilic Focus, Multiple                      35 (70%)     40 (80%)     32 (64%)                                            
      Clear Cell Focus                                                           2 (4%)                                             
      Cyst                                                          1 (2%)                                                          
      Eosinophilic Focus                               1 (2%)       3 (6%)       1 (2%)                                             
      Eosinophilic Focus, Multiple                                  2 (4%)                                                          
      Fibrosis, Focal                                                            1 (2%)                                             
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)       1 (2%)                                             
      Hepatodiaphragmatic Nodule                       4 (8%)       5 (10%)      6 (12%)                                            
      Hyperplasia, Nodular                             4 (8%)       4 (8%)       3 (6%)                                             
      Inflammation, Granulomatous, Multiple            5 (10%)      9 (18%)     10 (20%)                                            
      Mixed Cell Focus                                 1 (2%)       2 (4%)       4 (8%)                                             
      Necrosis, Focal                                  1 (2%)       1 (2%)                                                          
      Vacuolization Cytoplasmic                        4 (8%)       2 (4%)       1 (2%)                                             
      Bile Duct, Dilatation                                         1 (2%)                                                          
      Bile Duct, Hyperplasia                          14 (28%)     15 (30%)     10 (20%)                                            
      Centrilobular, Necrosis, Multiple                1 (2%)                                                                       
      Serosa, Hemorrhage                               1 (2%)                                                                       
      Serosa, Inflammation, Suppurative                             1 (2%)                                                          
   Mesentery                                          (5)          (3)          (4)                                                 
      Fat, Inflammation, Chronic                       3 (60%)      1 (33%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      225.         450.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Inflammation, Focal, Granulomatous                                    1 (25%)                                            
      Fat, Necrosis, Focal                             4 (80%)      2 (67%)      2 (50%)                                            
   Pancreas                                           (49)         (24)         (50)                                                
      Polyarteritis, Multiple                                       1 (4%)                                                          
      Acinar Cell, Atrophy                             5 (10%)      4 (17%)      6 (12%)                                            
      Acinar Cell, Hyperplasia                         2 (4%)                    5 (10%)                                            
      Acinar Cell, Hyperplasia, Multiple                                         1 (2%)                                             
      Duct, Cyst                                                                 1 (2%)                                             
   Stomach                                            (49)         (24)         (50)                                                
      Forestomach, Edema                               1 (2%)       2 (8%)       2 (4%)                                             
      Forestomach, Inflammation, Chronic               1 (2%)                    1 (2%)                                             
      Forestomach, Ulcer                               1 (2%)       2 (8%)       3 (6%)                                             
      Forestomach, Ulcer, Multiple                                               2 (4%)                                             
      Glandular, Cyst, Multiple                                                  1 (2%)                                             
      Glandular, Mineralization                                     1 (4%)       4 (8%)                                             
      Glandular, Epithelium, Hyperplasia                                         1 (2%)                                             
   Tongue                                                                       (1)                                                 
      Hyperplasia, Squamous                                                      1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                                    (1)          (1)                                                 
      Aorta, Media, Hypertrophy                                     1 (100%)                                                        
   Heart                                              (50)         (25)         (50)                                                
      Congestion                                                                 1 (2%)                                             
      Fibrosis, Focal                                               1 (4%)                                                          
      Fibrosis, Multiple                                            1 (4%)       1 (2%)                                             
      Inflammation, Chronic                           35 (70%)     13 (52%)     29 (58%)                                            
      Atrium, Congestion                                                         1 (2%)                                             
      Atrium, Thrombosis                                            1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (25)         (50)                                                
      Accessory Adrenal Cortical Nodule                4 (8%)       4 (16%)      2 (4%)                                             
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                                                 1 (2%)                                             
      Degeneration, Cystic                             4 (8%)                    2 (4%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hypertrophy, Focal                               3 (6%)       3 (12%)      6 (12%)                                            
      Vacuolization Cytoplasmic                        5 (10%)      3 (12%)      3 (6%)                                             
   Adrenal Gland, Medulla                             (50)         (25)         (49)                                                
      Angiectasis                                                                1 (2%)                                             
      Congestion                                                                 1 (2%)                                             
      Hyperplasia, Focal                               4 (8%)       1 (4%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      225.         450.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Pituitary Gland                                    (49)         (37)         (48)                                                
      Cyst                                             1 (2%)                                                                       
      Cyst, Multiple                                   2 (4%)                                                                       
      Pars Distalis, Angiectasis                       4 (8%)       9 (24%)      4 (8%)                                             
      Pars Distalis, Cyst                              9 (18%)      6 (16%)      5 (10%)                                            
      Pars Distalis, Cyst, Multiple                   16 (33%)      7 (19%)      6 (13%)                                            
      Pars Distalis, Hemorrhage                                     3 (8%)                                                          
      Pars Distalis, Hyperplasia, Focal                7 (14%)      7 (19%)      6 (13%)                                            
      Pars Distalis, Inflammation, Focal,                                                                                           
          Granulomatous                                                          1 (2%)                                             
   Thyroid Gland                                      (50)         (27)         (50)                                                
      Angiectasis                                                   1 (4%)                                                          
      Degeneration, Cystic                                          1 (4%)                                                          
      Ultimobranchial Cyst                             2 (4%)                                                                       
      C-Cell, Hyperplasia                             10 (20%)      2 (7%)       3 (6%)                                             
      Follicle, Cyst                                   1 (2%)                                                                       
      Follicular Cell, Hyperplasia                     1 (2%)       1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (48)         (22)         (46)                                                
      Atrophy                                                       1 (5%)       1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia                                      2 (4%)       1 (5%)                                                          
      Inflammation, Suppurative                        4 (8%)       2 (9%)       3 (7%)                                             
      Metaplasia, Squamous                                                       1 (2%)                                             
      Necrosis                                         1 (2%)                                                                       
      Duct, Cyst                                      19 (40%)      4 (18%)     11 (24%)                                            
   Ovary                                              (50)         (24)         (50)                                                
      Cyst                                             5 (10%)                   3 (6%)                                             
      Hyperplasia, Tubular                                                       1 (2%)                                             
   Uterus                                             (50)         (32)         (50)                                                
      Decidual Reaction                                1 (2%)                    1 (2%)                                             
      Dilatation                                       4 (8%)       1 (3%)       2 (4%)                                             
      Inflammation, Suppurative                        1 (2%)                                                                       
      Cervix, Cyst                                     2 (4%)       1 (3%)                                                          
      Endometrium, Fibrosis                            1 (2%)                                                                       
      Endometrium, Fibrosis, Focal                     1 (2%)                                                                       
      Endometrium, Hyperplasia, Cystic                 6 (12%)      3 (9%)       7 (14%)                                            
      Endometrium, Hyperplasia, Glandular                           1 (3%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      225.         450.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Vagina                                             (2)                       (4)                                                 
      Cyst                                             1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (24)         (50)                                                
      Hyperplasia, Reticulum Cell                                                2 (4%)                                             
      Myelofibrosis                                    3 (6%)                    1 (2%)                                             
      Myeloid Cell, Hyperplasia                        1 (2%)       1 (4%)                                                          
   Lymph Node                                         (50)         (26)         (50)                                                
      Mediastinal, Hyperplasia, Lymphoid                            1 (4%)                                                          
      Pancreatic, Inflammation, Granulomatous                                    1 (2%)                                             
   Lymph Node, Mandibular                             (49)         (23)         (50)                                                
      Hyperplasia, Lymphoid                            1 (2%)       1 (4%)       1 (2%)                                             
   Lymph Node, Mesenteric                             (49)         (24)         (49)                                                
      Depletion Lymphoid                               1 (2%)       1 (4%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)       1 (4%)                                                          
      Pigmentation                                     1 (2%)       1 (4%)                                                          
   Spleen                                             (48)         (49)         (50)                                                
      Atrophy                                                       2 (4%)       1 (2%)                                             
      Fibrosis                                                      1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                 3 (6%)       8 (16%)      3 (6%)                                             
      Necrosis                                                      1 (2%)                                                          
      Pigmentation                                     7 (15%)      9 (18%)      3 (6%)                                             
   Thymus                                             (48)         (21)         (47)                                                
      Atrophy                                                       1 (5%)                                                          
      Cyst, Multiple                                                             2 (4%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Mediastinum, Hemorrhage                                                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)                                                
      Hyperplasia, Lobular                             6 (12%)      7 (14%)      3 (6%)                                             
      Duct, Cyst                                      42 (84%)     35 (70%)     23 (46%)                                            
   Skin                                               (50)         (28)         (50)                                                
      Cyst Epithelial Inclusion                        1 (2%)                                                                       
      Hemorrhage                                       1 (2%)                                                                       
      Ulcer                                                         1 (4%)                                                          
      Subcutaneous Tissue, Thrombosis, Multiple                     1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      225.         450.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (28)         (50)                                                
      Calvarium, Hyperostosis                          2 (4%)       4 (14%)      2 (4%)                                             
      Femur, Fracture                                                            1 (2%)                                             
   Skeletal Muscle                                    (2)                       (1)                                                 
      Diaphragm, Inflammation, Chronic                 1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (24)         (50)                                                
      Compression                                      5 (10%)      6 (25%)      1 (2%)                                             
      Hydrocephalus                                                 1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (30)         (50)                                                
      Congestion                                       2 (4%)       5 (17%)      6 (12%)                                            
      Hemorrhage                                       1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 3 (6%)                    1 (2%)                                             
      Alveolus, Pigmentation                                        1 (3%)       2 (4%)                                             
      Bronchus, Foreign Body                                                     1 (2%)                                             
      Lymphatic, Foreign Body                          1 (2%)       2 (7%)       1 (2%)                                             
      Mediastinum, Edema                                                         1 (2%)                                             
      Mediastinum, Foreign Body                                     1 (3%)       2 (4%)                                             
      Mediastinum, Hemorrhage                                                    2 (4%)                                             
      Peribronchial, Infiltration Cellular,                                                                                         
          Lymphocyte                                                             1 (2%)                                             
   Nose                                               (50)         (24)         (50)                                                
      Nasolacrimal Duct, Inflammation, Suppurative     2 (4%)                    1 (2%)                                             
   Trachea                                            (50)         (24)         (50)                                                
      Inflammation, Suppurative                                                  1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                             (1)          (5)                                                 
      Inflammation, Suppurative                                     1 (100%)                                                        
   Eye                                                (1)          (1)          (3)                                                 
      Cataract                                                                   2 (67%)                                            
      Cataract, Multiple                               1 (100%)                                                                     
      Cornea, Edema                                                 1 (100%)                                                        
      Retina, Degeneration                             1 (100%)     1 (100%)     2 (67%)                                            
   Zymbal's Gland                                                  (2)          (1)                                                 
      Inflammation, Suppurative                                     1 (50%)                                                         
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      225.         450.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (24)         (49)                                                
      Fibrosis, Focal                                  1 (2%)                                                                       
      Infarct, Multiple                                                          1 (2%)                                             
      Nephropathy, Chronic                            23 (47%)      7 (29%)     19 (39%)                                            
      Cortex, Cyst                                     1 (2%)                                                                       
      Medulla, Cyst                                    1 (2%)                                                                       
      Renal Tubule, Degeneration                                    1 (4%)                                                          
      Renal Tubule, Dilatation                         1 (2%)                    1 (2%)                                             
      Renal Tubule, Mineralization                    10 (20%)      2 (8%)      19 (39%)                                            
      Renal Tubule, Pigmentation                       4 (8%)                    3 (6%)                                             
   Urinary Bladder                                    (50)         (24)         (50)                                                
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia             1 (2%)                    1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                               6            7            3                                                  
    Moribund                                          19           13           12                                                  
    Dosing Accident                                    1            3            3                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                24           27           32                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (48)         (17)         (49)                                                
      Parasite Metazoan                                1 (2%)                                                                       
   Intestine Large, Colon                             (47)         (21)         (50)                                                
      Fibrosis, Focal                                                            1 (2%)                                             
      Parasite Metazoan                                7 (15%)      1 (5%)       8 (16%)                                            
      Ulcer                                                                      1 (2%)                                             
   Intestine Large, Rectum                            (47)         (19)         (49)                                                
      Parasite Metazoan                                             2 (11%)      1 (2%)                                             
   Intestine Small, Ileum                             (46)         (18)         (49)                                                
      Hyperplasia, Lymphoid                            2 (4%)                    5 (10%)                                            
   Intestine Small, Jejunum                           (46)         (17)         (50)                                                
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Metaplasia, Osseous                                           1 (6%)                                                          
   Liver                                              (50)         (50)         (50)                                                
      Basophilic Focus                                 7 (14%)      2 (4%)       5 (10%)                                            
      Basophilic Focus, Multiple                      13 (26%)     20 (40%)     18 (36%)                                            
      Clear Cell Focus                                 4 (8%)                    2 (4%)                                             
      Clear Cell Focus, Multiple                                                 3 (6%)                                             
      Congestion                                                    1 (2%)       1 (2%)                                             
      Degeneration, Cystic                             1 (2%)       1 (2%)       4 (8%)                                             
      Eosinophilic Focus                               4 (8%)                    1 (2%)                                             
      Eosinophilic Focus, Multiple                                               1 (2%)                                             
      Fibrosis                                                      1 (2%)                                                          
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)       1 (2%)                                             
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Hepatodiaphragmatic Nodule                       5 (10%)      4 (8%)       7 (14%)                                            
      Hyperplasia, Nodular                             4 (8%)       4 (8%)       6 (12%)                                            
      Inflammation, Granulomatous, Multiple            1 (2%)       1 (2%)       3 (6%)                                             
      Mixed Cell Focus                                 3 (6%)                    4 (8%)                                             
      Mixed Cell Focus, Multiple                       1 (2%)       2 (4%)                                                          
      Necrosis, Focal                                               1 (2%)                                                          
      Vacuolization Cytoplasmic                        6 (12%)      8 (16%)     11 (22%)                                            
      Bile Duct, Hyperplasia                          45 (90%)     35 (70%)     38 (76%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Centrilobular, Degeneration                      2 (4%)       1 (2%)       3 (6%)                                             
      Centrilobular, Necrosis                          1 (2%)                    1 (2%)                                             
   Mesentery                                          (11)         (10)         (19)                                                
      Inflammation, Chronic                                         2 (20%)                                                         
      Metaplasia, Osseous                              1 (9%)                                                                       
      Polyarteritis                                                              1 (5%)                                             
      Fat, Inflammation, Focal, Granulomatous                       1 (10%)      2 (11%)                                            
      Fat, Mineralization, Focal                       1 (9%)       1 (10%)                                                         
      Fat, Necrosis, Focal                             9 (82%)      9 (90%)     13 (68%)                                            
   Pancreas                                           (50)         (22)         (50)                                                
      Polyarteritis                                    3 (6%)                    6 (12%)                                            
      Acinar Cell, Atrophy                            18 (36%)      7 (32%)     21 (42%)                                            
      Acinar Cell, Hyperplasia                         2 (4%)       2 (9%)       4 (8%)                                             
      Acinar Cell, Hyperplasia, Multiple                                         1 (2%)                                             
   Pharynx                                            (1)                                                                           
      Palate, Hyperplasia, Squamous                    1 (100%)                                                                     
   Stomach                                            (50)         (29)         (50)                                                
      Forestomach, Cyst                                             1 (3%)                                                          
      Forestomach, Edema                               1 (2%)       3 (10%)      1 (2%)                                             
      Forestomach, Fibrosis, Chronic                                1 (3%)                                                          
      Forestomach, Hyperkeratosis                                   1 (3%)                                                          
      Forestomach, Inflammation, Chronic               2 (4%)       3 (10%)      1 (2%)                                             
      Forestomach, Mineralization                      1 (2%)                                                                       
      Forestomach, Polyarteritis                       1 (2%)                    1 (2%)                                             
      Forestomach, Ulcer                               1 (2%)       2 (7%)       1 (2%)                                             
      Forestomach, Epithelium, Hyperplasia             1 (2%)       3 (10%)      2 (4%)                                             
      Glandular, Mineralization                        2 (4%)                                                                       
      Glandular, Polyarteritis                                                   2 (4%)                                             
   Tongue                                             (3)          (4)                                                              
      Hemorrhage, Focal                                             1 (25%)                                                         
      Hyperkeratosis                                                1 (25%)                                                         
      Inflammation, Focal                              1 (33%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)                                                                           
      Mesenteric Artery, Polyarteritis                 1 (100%)                                                                     
   Heart                                              (50)         (25)         (50)                                                
      Congestion                                                    1 (4%)                                                          
      Fibrosis, Focal                                                            1 (2%)                                             
      Inflammation, Chronic                           46 (92%)     21 (84%)     43 (86%)                                            
      Mineralization                                                1 (4%)                                                          
      Atrium, Congestion                                            1 (4%)       4 (8%)                                             
      Atrium, Fibrosis                                                           1 (2%)                                             
      Atrium, Thrombosis                                            1 (4%)       4 (8%)                                             
      Valve, Bacterium                                 1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Valve, Thrombosis                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (48)         (24)         (49)                                                
      Accessory Adrenal Cortical Nodule                                          2 (4%)                                             
      Degeneration, Cystic                                                       4 (8%)                                             
      Hyperplasia, Focal                               5 (10%)                   3 (6%)                                             
      Hypertrophy, Focal                               2 (4%)       1 (4%)                                                          
      Vacuolization Cytoplasmic                       11 (23%)      5 (21%)      5 (10%)                                            
   Adrenal Gland, Medulla                             (48)         (23)         (49)                                                
      Hemorrhage                                                    1 (4%)                                                          
      Hyperplasia, Focal                               5 (10%)      1 (4%)       1 (2%)                                             
      Hyperplasia, Focal, Multiple                                               2 (4%)                                             
      Mineralization                                                             1 (2%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Vacuolization Cytoplasmic                        1 (2%)                                                                       
   Parathyroid Gland                                  (46)         (22)         (48)                                                
      Hyperplasia                                      1 (2%)       1 (5%)                                                          
   Pituitary Gland                                    (48)         (28)         (49)                                                
      Pars Distalis, Angiectasis                       3 (6%)       1 (4%)       2 (4%)                                             
      Pars Distalis, Cyst                              4 (8%)       2 (7%)       1 (2%)                                             
      Pars Distalis, Cyst, Multiple                    1 (2%)       1 (4%)                                                          
      Pars Distalis, Hemorrhage                                     1 (4%)       1 (2%)                                             
      Pars Distalis, Hyperplasia, Focal                8 (17%)      4 (14%)      3 (6%)                                             
      Pars Intermedia, Hemorrhage                                   1 (4%)                                                          
   Thyroid Gland                                      (50)         (25)         (50)                                                
      Hyperplasia, Cystic                              1 (2%)                                                                       
      Ultimobranchial Cyst                                                       1 (2%)                                             
      C-Cell, Hyperplasia                              9 (18%)      5 (20%)     13 (26%)                                            
      Follicle, Cyst                                   2 (4%)                    1 (2%)                                             
      Follicle, Hyperplasia, Cystic                                              1 (2%)                                             
      Follicular Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (23)         (50)                                                
      Edema                                                                      1 (2%)                                             
   Preputial Gland                                    (48)         (24)         (50)                                                
      Atrophy                                         12 (25%)      3 (13%)     13 (26%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Fibrosis                                         1 (2%)       2 (8%)                                                          
      Hyperplasia                                                   1 (4%)       1 (2%)                                             
      Inflammation, Chronic                            4 (8%)                    1 (2%)                                             
      Inflammation, Suppurative                        8 (17%)      9 (38%)      2 (4%)                                             
      Necrosis                                                                   1 (2%)                                             
      Duct, Cyst                                      10 (21%)      5 (21%)      7 (14%)                                            
   Prostate                                           (49)         (24)         (49)                                                
      Cyst                                                          1 (4%)                                                          
      Cyst, Multiple                                                2 (8%)                                                          
      Fibrosis                                                                   1 (2%)                                             
      Inflammation, Chronic                                         2 (8%)       2 (4%)                                             
      Inflammation, Suppurative                       16 (33%)     11 (46%)     17 (35%)                                            
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Seminal Vesicle                                    (50)         (25)         (50)                                                
      Atrophy                                                       1 (4%)                                                          
      Dilatation                                                    2 (8%)                                                          
      Inflammation, Chronic                                         1 (4%)                                                          
      Epithelium, Hyperplasia                                       1 (4%)                                                          
   Testes                                             (50)         (50)         (50)                                                
      Atrophy                                         15 (30%)     19 (38%)     22 (44%)                                            
      Mineralization                                                             1 (2%)                                             
      Necrosis                                         1 (2%)                                                                       
      Bilateral, Atrophy                                                         1 (2%)                                             
      Bilateral, Interstitial Cell, Hyperplasia        8 (16%)      2 (4%)       2 (4%)                                             
      Interstitial Cell, Atrophy                       2 (4%)                                                                       
      Interstitial Cell, Hyperplasia                   7 (14%)      8 (16%)     14 (28%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Blood                                              (2)          (2)                                                              
      Leukocytosis                                     1 (50%)                                                                      
   Bone Marrow                                        (50)         (23)         (50)                                                
      Atrophy                                          1 (2%)                                                                       
      Myelofibrosis                                    1 (2%)                                                                       
      Myeloid Cell, Hyperplasia                        1 (2%)       1 (4%)       1 (2%)                                             
   Lymph Node                                         (50)         (25)         (50)                                                
      Axillary, Hyperplasia, Lymphoid                                            1 (2%)                                             
      Inguinal, Cyst                                                1 (4%)                                                          
      Inguinal, Hyperplasia, Lymphoid                  1 (2%)                    1 (2%)                                             
      Mediastinal, Hemorrhage                                       2 (8%)                                                          
      Mediastinal, Hyperplasia, Histiocytic                         1 (4%)                                                          
      Mediastinal, Hyperplasia, Lymphoid               1 (2%)       1 (4%)                                                          
      Mediastinal, Necrosis                                         1 (4%)                                                          
      Mediastinal, Pigmentation                                                  1 (2%)                                             
      Pancreatic, Hyperplasia, Lymphoid                1 (2%)                                                                       
   Lymph Node, Mandibular                             (48)         (21)         (49)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Cyst                                                          1 (5%)       1 (2%)                                             
      Cyst, Multiple                                                             2 (4%)                                             
      Hyperplasia, Lymphoid                            5 (10%)      1 (5%)       2 (4%)                                             
      Lymphocyte, Necrosis                                                       1 (2%)                                             
   Lymph Node, Mesenteric                             (48)         (23)         (50)                                                
      Angiectasis                                      1 (2%)       1 (4%)                                                          
      Cyst, Multiple                                   1 (2%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)                                             
      Lymphocyte, Necrosis                                                       1 (2%)                                             
   Spleen                                             (50)         (45)         (50)                                                
      Atrophy                                                       1 (2%)       1 (2%)                                             
      Atrophy, Focal                                                             1 (2%)                                             
      Congestion                                                    1 (2%)                                                          
      Developmental Malformation                                                 1 (2%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)       1 (2%)                                             
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                            2 (4%)                                                                       
      Necrosis                                                      2 (4%)                                                          
      Pigmentation                                                  1 (2%)                                                          
   Thymus                                             (43)         (20)         (49)                                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (44)         (23)         (48)                                                
      Hyperplasia, Lobular                             1 (2%)       1 (4%)       1 (2%)                                             
      Duct, Cyst                                       6 (14%)      8 (35%)     10 (21%)                                            
   Skin                                               (50)         (37)         (50)                                                
      Cyst                                             1 (2%)                                                                       
      Cyst Epithelial Inclusion                                     1 (3%)       4 (8%)                                             
      Fibrosis                                         1 (2%)       1 (3%)                                                          
      Ulcer                                            1 (2%)                                                                       
      Epidermis, Hyperplasia                           1 (2%)                                                                       
      Epidermis, Hyperplasia, Focal                    1 (2%)       3 (8%)       1 (2%)                                             
      Subcutaneous Tissue, Hemorrhage, Chronic         1 (2%)                                                                       
      Subcutaneous Tissue, Inflammation,                                                                                            
          Granulomatous                                                          1 (2%)                                             
      Subcutaneous Tissue, Necrosis                    1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (1)          (1)          (3)                                                 
      Abdominal, Metaplasia, Osseous                   1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (24)         (50)                                                
      Compression                                      1 (2%)       2 (8%)       1 (2%)                                             
      Hemorrhage                                       5 (10%)      1 (4%)       1 (2%)                                             
      Hippocampus, Vacuolization Cytoplasmic           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (29)         (50)                                                
      Congestion                                       6 (12%)      9 (31%)      5 (10%)                                            
      Edema                                            1 (2%)                                                                       
      Foreign Body                                     2 (4%)                                                                       
      Hemorrhage                                       1 (2%)       1 (3%)       2 (4%)                                             
      Inflammation, Granulomatous                                   1 (3%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 1 (2%)       1 (3%)       1 (2%)                                             
      Alveolus, Edema                                               1 (3%)                                                          
      Alveolus, Foreign Body                                        1 (3%)       2 (4%)                                             
      Alveolus, Pigmentation                                        2 (7%)                                                          
      Artery, Embolus Tumor                                                      1 (2%)                                             
      Artery, Embolus Tumor, Multiple                               1 (3%)                                                          
      Artery, Mineralization, Multiple                              1 (3%)                                                          
      Lymphatic, Foreign Body                                       3 (10%)      3 (6%)                                             
      Perivascular, Foreign Body                                                 1 (2%)                                             
      Subpleura, Hemorrhage                                                      1 (2%)                                             
   Nose                                               (50)         (23)         (49)                                                
      Lumen, Foreign Body                              1 (2%)                                                                       
      Lumen, Fungus                                    7 (14%)      2 (9%)       9 (18%)                                            
      Lumen, Inflammation, Suppurative                 8 (16%)      2 (9%)       8 (16%)                                            
      Nasolacrimal Duct, Inflammation, Suppurative     2 (4%)                    3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (7)          (5)          (3)                                                 
      Cataract                                         3 (43%)      3 (60%)      3 (100%)                                           
      Hemorrhage                                       1 (14%)                                                                      
      Inflammation, Suppurative                        1 (14%)                                                                      
      Retina, Degeneration                             4 (57%)                   3 (100%)                                           
   Harderian Gland                                    (1)                                                                           
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05002-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        GAMMA-BUTYROLACTONE                                    Date: 09/02/94  
Route: GAVAGE                                                                                                     Time: 17:49:23  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      112.         225.                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Pigmentation                                     1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (23)         (50)                                                
      Bacterium                                        1 (2%)                                                                       
      Hydronephrosis                                                2 (9%)                                                          
      Hydronephrosis, Multiple                                      1 (4%)                                                          
      Infarct                                          1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Nephropathy, Chronic                            41 (82%)     15 (65%)     46 (92%)                                            
      Medulla, Necrosis                                             1 (4%)                                                          
      Pelvis, Hemorrhage                                            1 (4%)                                                          
      Pelvis, Necrosis                                              1 (4%)                                                          
      Renal Tubule, Mineralization                     1 (2%)       1 (4%)       2 (4%)                                             
      Renal Tubule, Pigmentation                       1 (2%)       1 (4%)       4 (8%)                                             
   Urinary Bladder                                    (48)         (22)         (50)                                                
      Inflammation, Chronic                                         1 (5%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------